Covered recipient · General Payments record
MICHAEL BARMACH
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,910.04
- Reported across 178 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $489.68 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $118.09 | 6 |
| Amgen Inc. | $73.88 | 4 |
| Lilly USA, LLC | $71.40 | 3 |
| Acerta Pharma LLC | $58.41 | 3 |
| GlaxoSmithKline, LLC. | $40.26 | 2 |
| Novo Nordisk AS | $33.48 | 2 |
| PFIZER INC. | $33.11 | 2 |
| Exact Sciences Corporation | $29.75 | 1 |
| E.R. Squibb & Sons, L.L.C. | $17.27 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $14.03 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.44 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280815 | CMS |
| ABBVIE INC. | $20.33 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280817 | CMS |
| ABBVIE INC. | $21.17 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280819 | CMS |
| ABBVIE INC. | $21.84 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280821 | CMS |
| ABBVIE INC. | $14.81 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280823 | CMS |
| ABBVIE INC. | $20.50 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280825 | CMS |
| Amgen Inc. | $14.94 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115440352 | CMS |
| Amgen Inc. | $20.48 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115440356 | CMS |
| Amgen Inc. | $18.57 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115440359 | CMS |
| Amgen Inc. | $19.89 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115440363 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.78 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105896204 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.75 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104717635 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.88 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104635863 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $14.03 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086242720 | CMS |
| E.R. Squibb & Sons, L.L.C. | $17.27 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101541460 | CMS |
| Exact Sciences Corporation | $29.75 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114585729 | CMS |
| GlaxoSmithKline, LLC. | $20.45 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116724702 | CMS |
| GlaxoSmithKline, LLC. | $19.81 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116067074 | CMS |
| Lilly USA, LLC | $21.20 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135188863 | CMS |
| Lilly USA, LLC | $20.28 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135226377 | CMS |
| Lilly USA, LLC | $29.92 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135226373 | CMS |
| Novo Nordisk Inc | $18.11 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096605071 | CMS |
| Novo Nordisk Inc | $15.37 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096818054 | CMS |
| PFIZER INC. | $17.00 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131316542 | CMS |
| PFIZER INC. | $16.11 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131147192 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.